Business Context and Reporting Period
Company: UY Scuti Acquisition Corp. (UYSC)
Filing Type: Form 8-K (Current Report)
Date of Report: March 25, 2026
Reporting Period: The filing addresses events occurring between March 2, 2026, and March 25, 2026, specifically regarding the adjournment of an Extraordinary General Meeting and amendments to the Definitive Proxy Statement filed on March 2, 2026.
Business Context: The Company is a Cayman Islands-based special purpose acquisition company (SPAC) listed on The Nasdaq Stock Market. It is seeking shareholder approval to extend the deadline to consummate a business combination.
Key Financial Metrics
This filing is a current report regarding corporate governance and meeting logistics; it does not contain audited financial statements, revenue, profit, or cash flow data.
- Trust Account Extension Fee: The Sponsor and/or its designees are required to deposit $450,000 into the trust account for each three-month extension period if the proposals are approved.
- Previous Extension Fee (for context): The filing notes the prior requirement was $575,000 per extension period.
- Liquidity/Trust Withdrawals: The proposed Trust Amendment prohibits the Company from withdrawing interest from the trust account to pay dissolution expenses.
Material Changes and Proposals
The filing details significant changes to the terms of the proposed Charter and Trust Amendments compared to the initial proxy statement:
- Extension Capability: The Company proposes to amend its Charter to allow up to four (4) extensions of three months each, extending the business combination deadline to April 1, 2027 (previously limited to two extensions until October 1, 2026).
- Reduced Extension Fee: The required deposit per extension period has been revised downward from $575,000 to $450,000.
- Cure Period: A new provision grants the Company a 30-day cure period to pay any past-due extension fees. Failure to pay within this period will trigger immediate liquidation of the trust account and distribution to public shareholders.
- Meeting Adjournment: The Extraordinary General Meeting was adjourned from March 19, 2026, to March 25, 2026, and subsequently to March 31, 2026, to allow additional time for proxy solicitation.
- Redemption Deadline: The deadline for shareholders to redeem shares has been extended to March 27, 2026.
Outlook, Risks, and Management Commentary
Management Commentary: Management states the adjournment is necessary to solicit additional proxies. If the proposals are approved, the Company will not seek another shareholder vote for further changes to extension terms.
Risks and Contingencies:
- Liquidation Risk: If the Sponsor fails to deposit the $450,000 extension fee and fails to cure the default within 30 days, the Company must liquidate the trust account.
- Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ from expectations regarding meeting dates and redemption deadlines.
- Shareholder Action: Shareholders of record as of February 19, 2026, are entitled to vote. Proxies previously submitted remain valid unless revoked.
Investor Verification Checklist
- Verify the redemption deadline is March 27, 2026, if intending to redeem shares.
- Confirm the new meeting date is March 31, 2026, at 10:00 a.m. Eastern Time.
- Review the revised extension fee of $450,000 per period and the new 30-day cure period provision in the Trust Amendment.
- Check the Definitive Proxy Statement (filed March 2, 2026) and its supplements (Exhibits 99.1 and 99.2) for full text of the resolutions.
- Ensure proxy instructions are submitted if shares are held in "street name" and the investor has not yet voted.